SCHEMBL13804183

SCHEMBL13804183

COc1ccc(NO)c(CCN)c1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TAAR1 Q96RJ0 3/20 0.60
ADRA1A P35348 1/20 0.60
HTR2A P28223 2/20 0.48
CYP1A2 P05177 2/20 0.48
HTR1A P08908 1/20 0.48
MAPT P10636 1/20 0.48
TSHR P16473 1/20 0.48
NFKB1 P19838 1/20 0.48
HTR1D P28221 1/20 0.48
HTR1B P28222 1/20 0.48
HTR2C P28335 1/20 0.48
HTR7 P34969 1/20 0.48
HTR6 P50406 1/20 0.48
HTR4 Q13639 1/20 0.48
TRPM8 Q7Z2W7 1/20 0.48
BLM P54132 1/20 0.47
PMP22 Q01453 1/20 0.47
NPSR1 Q6W5P4 1/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6676239 0.77 ADRA1A (0.49) TAAR1ADRA1AHTR2ACYP1A2HTR1A
SCHEMBL6676245 0.77 PTGIR (0.49) TAAR1ADRA1AHTR2ACYP1A2HTR1A
Hydrochloric Acid SCHEMBL6679353 0.76 PTGIR (0.48) TAAR1ADRA1AHTR2ACYP1A2HTR1A
Hydrochloric Acid SCHEMBL6679352 0.76 ADRA1A (0.48) TAAR1ADRA1AHTR2ACYP1A2HTR1A
SCHEMBL13804066 0.75 PKM (0.40) TAAR1ADRA1ACYP1A2MAPTMEN1
SCHEMBL479514 0.75 TAAR1 (1.00) TAAR1ADRA1AHTR2ACYP1A2
SCHEMBL506175 0.75 TAAR1 (0.68) TAAR1ADRA1AHTR2ACYP1A2HTR1A
SCHEMBL29491077 0.75 TAAR1 (1.00) TAAR1ADRA1AHTR2ACYP1A2
SCHEMBL13255038 0.75 TAAR1 (0.68) TAAR1ADRA1AHTR2ACYP1A2HTR1A
SCHEMBL30709158 0.75 TAAR1 (0.68) TAAR1ADRA1AHTR2ACYP1A2HTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2065382-A1 CGRP antagonists Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-03 EP disclosed
EP-2065381-A1 CGRP antagonists Boehringer Ingelheim Pharma GmbH & Co. KG (DE) 2009-06-03 EP disclosed
WO-2009065921-A2 NOVEL COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-05-28 WO disclosed
WO-2009050235-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed
WO-2009050232-A1 CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-04-23 WO disclosed
WO-2009034029-A2 1-SUBSTITUTED 4-HETEROCYCLYLPIPERIDINES FOR USE AS CGRP ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2009-03-19 WO disclosed